Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 324 participants.
Also called NCT05856851
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 324 participants
- Registry
-
NCT05856851
-
- Other papers using this trial's data
- Intra-Arterial Alteplase After Successful Endovascular Reperfusion in Patients Without Intravenous Thrombolysis: A Subgroup Analysis of the PEARL Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT05856851. Randomized; single masking; primary purpose treatment. Start 2023-08-01 (actual); primary completion 2025-01-15 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy
- Acronym
- PEARL
- Condition
- Stroke, Acute Ischemic
- Intervention (Drug)
- Alteplase
- Lead sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Collaborator
- Shenzhen Hospital of Southern Medical University
Record details
- Record id
cardio:ct-nct05856851- Content hash
e039431e18b6b17da5a4502bedba876e8133eab70aa449a8b40659de4fea4a6f